Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Halaban

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Biochemistry|July 23, 2025
The ERVK3-1 Microprotein Interacts with the HUSH ComplexAyodya Jayatissa, Nadiya Jaunbocus, Betel Erkalo, et al.
Cancer Immunology Research|December 7, 2017
A Serum Protein Signature Associated with Outcome after Anti-PD-1 Therapy in Metastatic MelanomaJeffrey S Weber, Mario Sznol, Ryan J Sullivan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correctionXinxing Li, Tao Liu, Antonella Bacchiocchi, et al.
Cancer Research|February 26, 2015
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic TargetsMarzia Scortegagna, Eric Lau, Tongwu Zhang, et al.
Cell|October 18, 2011
In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanomaFlorian A Karreth, Yvonne Tay, Daniele Perna, et al.
Nature Genetics|July 28, 2015
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomasMichael Krauthammer, Yong Kong, Antonella Bacchiocchi, et al.
Cancer Research|April 27, 2025
Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK InhibitorsJyoti Srivastava, Vipin K Yadav, Rachel V Jimenez, et al.
Cancer Cell|January 5, 2024
Interferon-stimulated neutrophils as a predictor of immunotherapy responseMadeleine Benguigui, Tim J Cooper, Prajakta Kalkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2011
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabJianda Yuan, Matthew Adamow, Brian A Ginsberg, et al.
Cell Reports|June 2, 2015
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 DeregulationHyungsoo Kim, Dennie T Frederick, Mitchell P Levesque, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Biochemistry|July 23, 2025
The ERVK3-1 Microprotein Interacts with the HUSH ComplexAyodya Jayatissa, Nadiya Jaunbocus, Betel Erkalo, et al.
Cancer Immunology Research|December 7, 2017
A Serum Protein Signature Associated with Outcome after Anti-PD-1 Therapy in Metastatic MelanomaJeffrey S Weber, Mario Sznol, Ryan J Sullivan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correctionXinxing Li, Tao Liu, Antonella Bacchiocchi, et al.
Cancer Research|February 26, 2015
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic TargetsMarzia Scortegagna, Eric Lau, Tongwu Zhang, et al.
Cell|October 18, 2011
In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanomaFlorian A Karreth, Yvonne Tay, Daniele Perna, et al.
Nature Genetics|July 28, 2015
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomasMichael Krauthammer, Yong Kong, Antonella Bacchiocchi, et al.
Cancer Research|April 27, 2025
Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK InhibitorsJyoti Srivastava, Vipin K Yadav, Rachel V Jimenez, et al.
Cancer Cell|January 5, 2024
Interferon-stimulated neutrophils as a predictor of immunotherapy responseMadeleine Benguigui, Tim J Cooper, Prajakta Kalkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2011
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabJianda Yuan, Matthew Adamow, Brian A Ginsberg, et al.
Cell Reports|June 2, 2015
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 DeregulationHyungsoo Kim, Dennie T Frederick, Mitchell P Levesque, et al.
Pageof 9